Nello Mainolfi
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $36.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,525693,043 held (−1%) | $111.44 | $393K | +0.9% |
| Oct 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,506687,537 held (−1%) | $112.42 | $619K | -0.0% |
| Oct 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,876682,661 held (−1%) | $113.24 | $552K | -0.7% |
| Oct 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,601675,060 held (−1%) | $114.43 | $870K | -1.8% |
| Oct 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 8,230666,830 held (−1%) | $115.40 | $950K | -2.6% |
| Oct 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 262666,568 held (−0%) | $116.12 | $30K | -3.2% |
| Jul 7SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 50,000666,568 held (−7%) | $119.00 | $6.0M | -5.5% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,883744,685 held (−0%) | $112.80 | $212K | -0.4% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6,626738,059 held (−1%) | $113.98 | $755K | -1.4% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 24,105713,954 held (−3%) | $114.96 | $2.8M | -2.2% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 44,050669,904 held (−6%) | $115.69 | $5.1M | -2.8% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,336666,568 held (−0%) | $116.56 | $389K | -3.6% |
| Apr 29SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 17,005679,190 held (−2%) | $80.74 | $1.4M | +39.2% |
| Apr 29SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 12,059667,131 held (−2%) | $81.70 | $985K | +37.6% |
| Apr 29SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 936666,195 held (−0%) | $82.45 | $77K | +36.3% |
| Feb 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 19,764676,431 held (−3%) | $89.78 | $1.8M | +25.2% |
| Feb 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,434670,997 held (−1%) | $90.39 | $491K | +24.4% |
| Feb 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,293667,704 held (−0%) | $91.76 | $302K | +22.5% |
| Feb 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,501666,203 held (−0%) | $92.81 | $139K | +21.1% |
| Feb 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 8666,195 held (−0%) | $93.49 | $748 | +20.2% |
| Dec 31SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 23,986669,091 held (−3%) | $77.95 | $1.9M | +44.2% |
| Dec 31SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6,014663,077 held (−1%) | $78.52 | $472K | +43.1% |
| Dec 8SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 100,000660,482 held (−13%) | $89.17 | $8.9M | +26.1% |
| Oct 29SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,862688,620 held (−0%) | $59.72 | $111K | +88.2% |
| Oct 29SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 24,511664,109 held (−4%) | $61.02 | $1.5M | +84.2% |
| Oct 29SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,627660,482 held (−1%) | $61.46 | $223K | +82.9% |
- Sell
CEO Nello Mainolfi sold $393K of KYMR at $111.44 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Nello Mainolfi sold $619K of KYMR at $112.42 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Nello Mainolfi sold $552K of KYMR at $113.24 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Nello Mainolfi sold $870K of KYMR at $114.43 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Nello Mainolfi sold $950K of KYMR at $115.40 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Nello Mainolfi sold $30K of KYMR at $116.12 — pre-scheduled 10b5-1 plan sale.